Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in U.S.
Pfizer, Inc. of New York and BioNTech SE of Mainz, Germany have announced that human clinical trials for an experimental COVID-19 vaccine they have co-developed, known as BNT162, have begun in the United States.1 As part of a global clinical development program, the first human subjects in the U.S. Phase I and Phase clinical II […]
New York Nursing Homes in Crisis During COVID-19 Pandemic
On Mar. 25, 2020, New York Governor Andrew Cuomo issued an order requiring nursing homes to accept on an expedited basis all new or returning residents with confirmed or presumed COVID-19 who are discharged from the hospital after being diagnosed as medically stable. The order states: No resident shall be denied re-admission or admission to […]
Healthy Clinical Trial Subjects Suffer Grade 3 Side Effects to Moderna’s mRNA COVID-19 Vaccine
On May 18, 2020, Moderna, Inc. of Cambridge, Massachusetts announced that it had obtained “positive interim clinical data” from a Phase 1 human clinical trial of its experimental mRNA-1273 COVID-19 vaccine that began on Mar. 16. The biotechnology company said that eight of the 45 healthy adult volunteer trial subjects developed antibodies that may provide […]
Autism Numbers Increase by 8.5 Percent in U.S.
According to the U.S. Centers for Disease Control and Prevention (CDC), the number of children diagnosed with autism in the United States continues to increase. In a report published on Mar. 27, 2020, the CDC estimated the prevalence of autism spectrum disorder (ASD) in the country is now 1 in 54 children—up from 1 in […]
Live Tuberculosis “Vaccine” Being Tested as a Treatment for COVID-19 Infections
Story Highlights Researchers at Texas A&M University and five other academic institutions have begun a phase 4 clinical trial re-purposing a live attenuated tuberculosis vaccine to treat COVID-19. The researchers believe that the TICE® BCG vaccine, which is licensed to prevent and treat bladder cancer, may help mitigate the severity of COVID-19. The research team […]
German Study Shows COVID-19 Might Not Be as Fatal as Previously Thought
A new study out of Germany using antibody testing shows that the coronavirus may not be as fatal as once previously thought. The study focused on one of the hardest hit regions in Germany called Heinsberg. It found that 15 percent of the population had antibodies for the virus in this area, suggesting that they […]